MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617072104 A) filed by Praxis Biotech LLC on June 10, 2026, for Conjugates Targeting Fibroblast Activation Protein And Uses Thereof.
Inventors include Belmar, Sebastian U. S. A. Country; Ureta Daz, Gonzalo Andrs; Bernales, Sebastian Pctus Application No; Nayak, Anjan Kumar; Panpatil, Dayanand; and Pujala, Brahmam Wo Publication No.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: Compounds and conjugates which modulate the Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g., cytotoxic drugs, proteins, immunomodulators, radioactive components, metal chelating groups/chelating agents, fluorescent dyes, or contrast agents) are described. Such compositions may find use in therapy for treatment of diseases or disorders, such as cancer, inflammation or another disease characterized by overexpression of FAP.
Disclaimer: Curated by HT Syndication.
